Abstract
The effect of pharmacones clathration with glycosides results in significant decrease of drug agent dosage. We investigated the clathrates of hypotensive agent Nifedipine with glycyrrhizic acid, which was prepared in molecular proportion 1:4 respectively. Present study was carried out on the calcium channels on neurons of Lymnaea stagnalis mollusc.
Keywords: Pharmacones clathration, Nifedipine, Glycyrrhizic acid, Calcium channels
Letters in Drug Design & Discovery
Title: Increase in Pharmacological Activity of Drugs in their Clathrates with Plant Glycosides
Volume: 4 Issue: 3
Author(s): T. G. Tolstikova, A. O. Bryzgalov, I. V. Sorokina, M. V. Hvostov, A. S. Ratushnyak, T. A. Zapara and O. G. Simonova
Affiliation:
Keywords: Pharmacones clathration, Nifedipine, Glycyrrhizic acid, Calcium channels
Abstract: The effect of pharmacones clathration with glycosides results in significant decrease of drug agent dosage. We investigated the clathrates of hypotensive agent Nifedipine with glycyrrhizic acid, which was prepared in molecular proportion 1:4 respectively. Present study was carried out on the calcium channels on neurons of Lymnaea stagnalis mollusc.
Export Options
About this article
Cite this article as:
Tolstikova G. T., Bryzgalov O. A., Sorokina V. I., Hvostov V. M., Ratushnyak S. A., Zapara A. T. and Simonova G. O., Increase in Pharmacological Activity of Drugs in their Clathrates with Plant Glycosides, Letters in Drug Design & Discovery 2007; 4 (3) . https://dx.doi.org/10.2174/157018007780077453
DOI https://dx.doi.org/10.2174/157018007780077453 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Medical Hypothermia-A Multispecialty Approach
Recent Patents on Cardiovascular Drug Discovery Alkaloids from Cyanobacteria with Diverse Powerful Bioactivities
Mini-Reviews in Medicinal Chemistry An Evidence-Based Systematic Review of Stevia by the Natural Standard Research Collaboration
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
CNS & Neurological Disorders - Drug Targets Discovery and ADMET: Where Are We Now
Current Topics in Medicinal Chemistry Obesity and Gastrointestinal Hormones-Dual Effect of Angiotensin II Receptor Blockade and a Partial Agonist of PPAR-γ
Current Vascular Pharmacology Hypertension in Older Patients
Current Hypertension Reviews Toll-Like Receptors: Link between “Danger” Ligands and Plaque Instability
Current Drug Targets Novel Atypical Antipsychotics: Metabolism and Therapeutic Drug Monitoring (TDM)
Current Drug Metabolism Patent Selections
Recent Patents on Cardiovascular Drug Discovery Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine ACE Inhibitory Peptides Derived from Aquatic Protein
Current Protein & Peptide Science Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging Pharmacological Risk Factors for Delirium after Cardiac Surgery: A Review
Current Neuropharmacology Role of PGE2 in Blood Pressure Regulation
Current Hypertension Reviews Clinical Efficacy of Remdesivir and Favipiravir in the Treatment of COVID-19 Patients: Scenario so far
Current Drug Research Reviews Mitochondria-Targeted Antioxidant Peptides
Current Pharmaceutical Design Regular Physical Activity and Vascular Aging
Current Pharmaceutical Design Opioids and Mechanical Ventilation
Current Drug Targets Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)